Product NDC: | 0093-0308 |
Proprietary Name: | Clemastine Fumarate |
Non Proprietary Name: | Clemastine Fumarate |
Active Ingredient(s): | 2.68 mg/1 & nbsp; Clemastine Fumarate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-0308 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073283 |
Marketing Category: | ANDA |
Start Marketing Date: | 19920401 |
Package NDC: | 0093-0308-01 |
Package Description: | 100 TABLET in 1 BOTTLE (0093-0308-01) |
NDC Code | 0093-0308-01 |
Proprietary Name | Clemastine Fumarate |
Package Description | 100 TABLET in 1 BOTTLE (0093-0308-01) |
Product NDC | 0093-0308 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clemastine Fumarate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19920401 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | CLEMASTINE FUMARATE |
Strength Number | 2.68 |
Strength Unit | mg/1 |
Pharmaceutical Classes |